Related Experiment Video
Updated: Nov 18, 2025

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
14.3K
Stereoscopic Depth Perception and Visuospatial Dysfunction in Alzheimer's Disease
1Department of Psychology, Keimyung University, Daegu 42601, Korea.
Healthcare (Basel, Switzerland)
|February 6, 2021
Summary
Alzheimer's disease patients and those with mild cognitive impairment show intact stereopsis for coarse depth cues. This suggests their visuospatial abilities are sufficient for daily tasks, aiding in early AD detection.
Area of Science:
- Neuroscience
- Ophthalmology
- Gerontology
Background:
- Visuospatial dysfunction is an early marker for Alzheimer's disease (AD).
- Stereopsis disturbance is a suspected cause of visuospatial deficits in AD.
- Previous studies on stereoacuity in AD patients yielded mixed results.
Purpose of the Study:
- To assess stereoscopic abilities in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI).
- To investigate the processing of coarse disparities, crucial for environmental depth perception, in AD and MCI patients.
Main Methods:
- Participants judged the relative closeness of two virtual cubes presented at different distances.
- Virtual cubes were manipulated for disparity type (absolute vs. relative), direction (crossed vs. uncrossed), and magnitude.
- Stereoscopic abilities were assessed by evaluating participants' capacity to process coarse disparities.
Main Results:
- Patients with AD and MCI performed as well as, or better than, elderly controls in processing coarse disparities.
- This indicates preserved capacity for depth perception supporting daily activities like driving and navigation.
- The findings challenge previous assumptions about stereopsis deficits in early AD.
Conclusions:
- Alzheimer's disease and mild cognitive impairment patients retain the ability to process coarse visual disparities.
- This capability supports essential real-world tasks, suggesting visuospatial deficits in AD may stem from other factors.
- Results can inform diagnostic tools and clinical trial measures for visuospatial dysfunction in AD.
Keywords:
Alzheimer’s disease (AD)binocular disparitybiomarkercoarse disparitymiddle temporal area (MT)mild cognitive impairment (MCI)preclinical ADstereopsisvisuospatial dysfunctionMore Related Videos
Related Concept Videos
Depth Perception and Spatial Vision
1.4K
Depth perception is the ability to perceive objects three-dimensionally. It relies on two types of cues: binocular and monocular. Binocular cues depend on the combination of images from both eyes and how the eyes work together. Since the eyes are in slightly different positions, each eye captures a slightly different image. This disparity between images, known as binocular disparity, helps the brain interpret depth. When the brain compares these images, it determines the distance to an object.
1.4K
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Visual Agnosia
639
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
639
Alzheimer's Disease: Treatment
581
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
581
Prosopagnosia
529
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
529

